Health Minister Mark Butler knew and agreed to his department's plan, which led to the deferral of almost 50 submissions to the March 2025 PBAC meeting, two days before evaluators were contacted and 13 days before the industry was officially informed. …
Officials 'gauged' evaluator capacity after the minister endorsed their plan
November 7, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - - Latest News -
Cynata completes patient enrolment in Phase 2 trial for aGvHD therapy
December 15, 2025 - - Australian Biotech -
Prescient secures European approval to launch PTX-100 trial for rare lymphoma
December 15, 2025 - - Australian Biotech -
Orthocell lodges European and UK regulatory application for Remplir
December 15, 2025 - - Australian Biotech -
Neuren wins second FDA approval for trofinetide with launch of formulation
December 15, 2025 - - Australian Biotech -
Dimerix completes adult recruitment in Phase 3 trial for FSGS treatment DMX-200
December 15, 2025 - - Australian Biotech -
Radiopharm Theranostics reports high success rate in Phase 2b imaging trial
December 15, 2025 - - Australian Biotech